(-)-Hinokinin

CAS No. 26543-89-5

(-)-Hinokinin( —— )

Catalog No. M31238 CAS No. 26543-89-5

(-)-Hinokinin has anti-genotoxic and anticarcinogenic potential.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 475 In Stock
50MG Get Quote In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    (-)-Hinokinin
  • Note
    Research use only, not for human use.
  • Brief Description
    (-)-Hinokinin has anti-genotoxic and anticarcinogenic potential.
  • Description
    (-)-Hinokinin has anti-genotoxic and anticarcinogenic potential. (-)-Hinokinin is an anti-chagasic drug, has no mutagenic effects in animal cell and bacterial systems, anxiety that target the DAT, NET, and GAT-1 transporters, it may serve as a tool to develop new therapeutic drugs for attention deficit hyperactivity disorder.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    26543-89-5
  • Formula Weight
    354.4
  • Molecular Formula
    C20H18O6
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO, Pyridine, Methanol, Ethanol, etc.
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.J Nat Prod. 2013 Oct 25;76(10):1889-95.
molnova catalog
related products
  • Calcium dobesilate

    Calcium dobesilate(CaD) has angioprotective properties and protects endothelial cells partly by ameliorating HG?induced inflammation.

  • UK-396082

    UK-396082 is a potent and selective inhibitor of activated thrombin-activatable fibrinolysis inhibitor (activated TAFI; TAFIa) with Ki of 10 nM.

  • FM04

    FM04 is an orally active and highly potent inhibitor of P-glycoprotein (P-gp) with an EC50 value of 83 nM. FM04 can interact with Q1193 and I1115 in human P-gp nucleotide binding domain 2 (NBD2).